Israel Englander Soligenix, Inc. Transaction History

Millennium Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.4 - $168.0 $4,097 - $1.72 Million	10,244 New	10,244 $5,000
Q2 2022 Aug 15, 2022	BUY	$0.4 - $0.75 $602 - $1,128	1,505 Added 11.5%	14,588 $9,000
Q1 2022 May 16, 2022	SELL	$0.61 - $0.75 $30,328 - $37,289	-49,719 Reduced 79.17%	13,083 $10,000
Q4 2021 Feb 14, 2022	BUY	$0.66 - $1.1 $21,933 - $36,555	33,232 Added 112.38%	62,802 $41,000
Q3 2021 Nov 15, 2021	BUY	$0.9 - $1.31 $26,613 - $38,736	29,570 New	29,570 $31,000
Q2 2020 Aug 14, 2020	SELL	$1.36 - $2.26 $24,575 - $40,838	-18,070 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$1.42 - $3.34 $25,659 - $60,353	18,070 New	18,070 $30,000
Q4 2017 Feb 14, 2018	SELL	$1.84 - $2.32 $27,818 - $35,076	-15,119 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$2.01 - $2.27 $30,389 - $34,320	15,119	15,119 $34,000

Ticker SNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,105,200
Market Cap $152M
Description
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has c...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.